This product is a recombinant antibody that recognizes Influenza A virus A/PR/8134 and A/HK/8/68 M2. The monoclonal antibody C40 reacts with the epitope of Influenza A virus A/PR/8134 and A/HK/8/68 M2.
Figure 1 Shows that antibody nos. 2074, N547, L66 and C40G1 bind to M2 on A/PR/8/34 virus infected MDCK cells.
Figure 2 Shows a comparison of protective efficacy of C40G1, C40G4 and L30.
IgG1 isotype M2 antibodies provide greater protection of animals from a lethal virus challenge than antibodies with weak binding affinity to M2 on viral infected MDCK cells.
Figure 3 Illustrates a comparison of M2 antibody binding to M2 peptide/BSA expressed on influenza virus infected cells.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
NABL-095 | Recombinant Anti-IAV M2 VHH Single Domain Antibody | WB, ELISA, IHC, FC, FuncS | Llama VHH |
There are currently no Customer reviews or questions for HPAB-1868-FY. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.